Vaxxinity announces collaboration on space medicine research with university of central florida

Cape canaveral, fla., jan. 18, 2024 (globe newswire) -- vaxxinity, inc. (nasdaq: vaxx ), a u.s. company pioneering the development of a new class of medicines, today announced a collaboration with the university of central florida (ucf) to advance space medicine research. the research, funded by a grant from the state of florida, aims to further the development of vaxxinity's active immunotherapies to prevent and mitigate muscle and bone wasting, which are well known health challenges related to long-term spaceflight, and which share biological mechanisms implicated in highly prevalent age-related diseases.
VAXX Ratings Summary
VAXX Quant Ranking